OpenAI discovered a sophisticated hidden recording device in one of its offices, leading to the arrest of an employee who planted it. The company confirmed no evidence of data theft but terminated the employee and involved the FBI. This incident adds to OpenAI's recent security challenges, including previous hacking incidents and internal breaches. OpenAI emphasizes its commitment to security and the use of AI to combat such threats, with investigations ongoing.
The OpenAI employee arrest story is presented here with market context from Pluang's Technology sector. For readers following Technology stocks, 69 out of 150 priced US stocks rose while 79 fell. Notable movers include GRAB at USD 2.99 with a -5.08% change and 91% buy order activity, LOGI at USD 102.84 with a +4.59% change and 100% sell order activity, and TTWO at USD 199.83 with a -4.31% change and 93% buy order activity. This data is as of Oct 14, 2026 04:21 WIB.
Targa Resources Corp. announced a quarterly cash dividend of $1.25 per common share for Q3 2026, payable on November 17, 2026, to shareholders of record as of October 30, 2026. The company will release its Q3 2026 financial results before market open...
Applied Materials projects sustained demand for its chipmaking equipment driven by AI infrastructure growth, expecting faster spending on wafer fab equipment through 2030. The company aims to increase its market share by over 2 percentage points from...
Gordon Haskett Capital Corporation set a $105 price target for Ollie's Bargain Outlet, suggesting an 18.1% upside from its current price around $89. The company’s board approved an additional $500 million share repurchase authorization, increasing to...
FRUIT Holdings, Inc. introduced PAVE, a new protocol designed to allow AI systems to call on human judgment and authority when needed. This approach ensures that human input retains its value, authority, and attribution within AI workflows, addressin...
Pomerantz LLP is investigating Stryker Corp. for potential securities fraud after the company revealed ongoing manufacturing problems in its peripheral vascular business. The issue, initially expected to be resolved in Q3 2026, has persisted into Q4,...
